COMPANION MEETING HANDOUTS

AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY




  Sunday, February 12, 2006 — 1:30 PM — Regency VI  

  • Strategies for Negotiating the Diagnostic Gray Zone: Morphologic and Molecular Pathology of Borderline Cases
  Moderators: Dani S. Zander, University of Texas Health Science Center at Houston Medical School, Houston, TX and Philip T. Cagle, The Methodist Hospital, Houston, TX
  Disclosure: Dr. Aysegul Sahin indicated she has grant or research support from Genentech Company. The other speakers had nothing to disclose.

Click here to download handout in 1-per-page format for the entire meeting (404KB)

Click here to download handout in 6-per-page format for the entire meeting (676KB)

Click any blue title below to display and print the handout for individual lecture(s):
1:30  Atypical Adenomatous Hyperplasia: A Putative Forerunner of Adenocarcinoma of the Lung - Armando Fraire, University of Massachusetts Medical School, Worcester, MA
2:00  Liver Tumor Gray Zones: How Do We Shine Some Light in There? - Neil Theise, Beth Israel Medical Center, New York, NY
2:30  Molecular Diagnostics in GI Neoplasia - Stanley Hamilton, University of Texas — M.D. Anderson Cancer Center, Houston, TX
3:00  Recess
3:30  Breast Lesions with Borderline Morphologic Features - Aysegul Sahin, University of Texas — M.D. Anderson Cancer Center, Houston, TX
4:00  Molecular Resolution of Endometrial Cancers - George Mutter, Harvard Medical School/Brigham & Women's Hospital, Boston, MA
4:30  Biomarker—assisted Detection of Early Tubal Carcinoma and its Precursors in BRCA (+) Women: Promise and Pitfalls - Christopher Crum, Harvard Medical School/Brigham & Women's Hospital, Boston, MA
Pathologists need strategies to solve key differential diagnostic problems that currently exist in a variety of anatomic sites. This symposia will attempt to demonstrate how advances in the understanding of pathogenesis can be applied to surgical pathology practice. Leading pathologists will focus upon 2-3 sets of morphologically similar entities, describing applications of new technologies and scientific insights to the diagnostic resolution of these processes.